Pediatric Nephrology

, Volume 22, Issue 1, pp 141–143

Regression of left ventricular hypertrophy in children with antihypertensive therapy

  • Prema Ramaswamy
  • Irene D. Lytrivi
  • Chikku Paul
  • Mary Golden
  • Juan C. Kupferman
Brief Report


Left ventricular hypertrophy (LVH) is a complication of hypertension that has received great attention in the adult population. Large-scale randomized control studies in adults have demonstrated that LVH regresses in response to pharmacologic intervention. While it is known that LVH occurs as a complication of hypertension in the pediatric population, few studies have focused on its regression with pharmacological intervention. We report on three cases of hypertension-induced LVH in the pediatric population and its regression after treatment with antihypertensive medications. This report brings to light the need for larger, prospective studies on the incidence, natural history, and treatment of LVH associated with hypertension in the pediatric population.


Pediatrics Hypertension Ventricular hypertrophy Regression 


  1. 1.
    Kannel WB, Dannenberg AL, Levy D (1987) Population implications for electrocardiographic left ventricular hypertrophy. Am J Cardiol 60:851–931CrossRefGoogle Scholar
  2. 2.
    Lauer MS, Anderson KM, Levy D (1991) Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 18:1287–1294PubMedGoogle Scholar
  3. 3.
    Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322:1561–1566PubMedCrossRefGoogle Scholar
  4. 4.
    Daniels SR, Loggie JM, Khoury P, Kimball TR (1998) Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation 97:1907–1911PubMedGoogle Scholar
  5. 5.
    Daniels SD, Meyer RA, Loggie JMH (1990) Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation 82:1243–1248PubMedGoogle Scholar
  6. 6.
    Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE (2003) A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 115:41–46PubMedCrossRefGoogle Scholar
  7. 7.
    Sorof JM, Alexandrov AV, Cardwell G, Portman RJ (2003) Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 111:61–66PubMedCrossRefGoogle Scholar
  8. 8.
    National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576CrossRefGoogle Scholar
  9. 9.
    DeSimone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, DeDivitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260PubMedCrossRefGoogle Scholar
  10. 10.
    De Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH (1995) Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 25:1056–1062PubMedCrossRefGoogle Scholar
  11. 11.
    Schmieder RE, Schlaich MP, Klingbeil AU, Martus P (1998) Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996). Nephrol Dial Transplant 13:564–569PubMedCrossRefGoogle Scholar
  12. 12.
    Cruickshank JM, Lewis J, Moore V, Dodd C (1992) Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 6:85–90PubMedGoogle Scholar
  13. 13.
    Dahlof B (1992) Regression of left ventricular hypertrophy- are there differences between antihypertensive agents? Cardiology 81:307–315PubMedCrossRefGoogle Scholar
  14. 14.
    Hanevold C, Waller J, Daniels S, Portman R, Sorof J (2004) The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children: a collaborative study of the international pediatric hypertension association. Pediatrics 113:328–333PubMedCrossRefGoogle Scholar
  15. 15.
    Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA (1994) Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634–1638PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2006

Authors and Affiliations

  • Prema Ramaswamy
    • 1
  • Irene D. Lytrivi
    • 1
  • Chikku Paul
    • 3
  • Mary Golden
    • 2
  • Juan C. Kupferman
    • 2
  1. 1.Division of Pediatric CardiologyMaimonides Infants and Children’s HospitalBrooklynUSA
  2. 2.Division of Pediatric Nephrology and HypertensionMaimonides Infants and Children’s HospitalBrooklynUSA
  3. 3.Department of PediatricsMaimonides Infants and Children’s HospitalBrooklynUSA

Personalised recommendations